Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Christmas could be in jeopardy for a third year as COVID-19 waves set to continue indefinitely, experts warn

COVID-19 threatens to thwart many Queenslanders' Christmas plans for a third consecutive year, but the New Year brings the hope of next-generation vaccines that may better dampen virus transmission.

ABC News

With supplies low, FDA authorizes plan to stretch limited monkeypox vaccine doses

The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.

WEKU

Cato Supreme Court Review Article on the Supreme Court's January 2022 Vaccine Mandate Decisions

I am one of the relatively few people who think the Court got both cases right.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

US will stretch monkeypox vaccine supply with smaller doses

U.S. health officials are endorsing a new monkeypox vaccination strategy designed to stretch limited supplies by allowing health professionals to vaccinate up to five people — instead of one — with each vial

The Independent UK

Monkeypox vaccine 'in short supply' as cases rise in Scotland

Scottish case numbers have risen by two in the last week, bringing the total figures to 69.

Daily Record

A vaccine for Lyme disease is in its final clinical trial

There isn't currently a Lyme disease vaccine on the U.S. market. Researchers are hoping to change that.

WEKU

Monkeypox vaccine ‘in short supply’ as cases rise by two in Scotland

A VACCINE for monkeypox is “in short supply globally” as cases increased by two in Scotland since last week.

The National (Scotland)

Read news from The Economist, FT, and more,
with one subscription

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Dow Jones Falls As Inflation Report Looms; Covid Vaccine Maker Crashes On Earnings

The Dow Jones Industrial Average fell Tuesday ahead of Wednesday's key inflation report. Vaccine maker Novavax crashed on earnings results.

Investors Business Daily

Children under 10 will get polio boosters as virus returns to UK after 40 years

Youngsters to be offered shots from Wednesday

The Independent UK

John Oliver slams Warner Bros for cancelling Batgirl: ‘Burning down my network’

‘We let the vaccine sit unused on a shelf in our reserves like an expired Chobani or a $90m movie on HBO Max,’ Oliver said

The Independent UK

Monkeypox fears build as number of cases in Greater Manchester rise ahead of Pride amid "stay home if ill" warning

'Manchester has been left behind when we could have been protected'

Manchester Evening News

Polio boosters for under-10s amid fears of spreading outbreak

The amount of poliovirus samples picked up suggests it has been passing from person to person.

Wales Online

Trial seeks to develop first Lyme disease vaccine in 2 decades

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

Axios

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap of Monday's Biotech Catalysts - End Of the Day Summary

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

Bangkok Post

Monkeypox immunity tests to begin

The Department of Medical Science is seeking volunteers who received the smallpox vaccine when it was still being widely administered prior to 1980 to test whether they have been left with any residual immunity against monkeypox having successfully cultivated test strains of the new virus in their laboratories.

Investors Business Daily

Novavax Stock Plummets As 'Market Dynamics' Crush Its 2022 Sales Outlook

Novavax widely missed second-quarter forecasts Tuesday, leading the Covid vaccine maker to slash its guidance and NVAX stock to crash.

Investors Business Daily

Dow Jones Futures: Market Rally Faces Key Inflation Report; Covid Vaccine Maker Crashes On Earnings

Dow Jones futures were lower after Monday's stock market action ahead of Wednesday's inflation report — the consumer price index.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Major test of first possible Lyme vaccine in 20 years begins

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years

ABC News

Monkeypox vaccines have arrived in Victoria. Here's how the rollout will work

The first 3,500 doses will be available to Victorians most at risk of contracting the virus, which has spread to more than 70 countries and infected about 26,000 people around the world.

Daily Mirror

Polio booster to be given to under-10s to prevent first UK outbreak in 50 years

The UK Health Security Agency has repeatedly detected the poliovirus in London’s sewage works and is now calling on parents to make sure their children are fully vaccinated

The Conversation

Altruism – but also vulnerability – drive healthy volunteers to take part in clinical research

When UK authorities granted permission in October 2020 for the first controlled infection study to be carried out to test the anti-Covid-19 vaccine Oxford University had just developed, reactions ranged from disbelief to disapproval.

Edinburgh Live

Scottish monkeypox cases rise to 67 as WHO experts declare global emergency

Monkeypox cases across the UK are on the rise. Amidst World Health Organisation concerns, Public Health Scotland's vaccine program is getting under way despite limited global supply.

Los Angeles Times

Sex pods? Long sleeves? Californians try to cut monkeypox risk while waiting for shots

LOS ANGELES — As Kelechi Kalu books gigs as a musician, he wonders whether he is putting himself at risk for monkeypox.

The Independent UK

BioNTech reports strong first half, expects demand to grow

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

1 … 158 159 160 161

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

485 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.